These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31330214)

  • 1. Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions.
    Da Silva-Candal A; Brown T; Krishnan V; Lopez-Loureiro I; Ávila-Gómez P; Pusuluri A; Pérez-Díaz A; Correa-Paz C; Hervella P; Castillo J; Mitragotri S; Campos F
    J Control Release; 2019 Sep; 309():94-105. PubMed ID: 31330214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium.
    Kolhar P; Anselmo AC; Gupta V; Pant K; Prabhakarpandian B; Ruoslahti E; Mitragotri S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10753-8. PubMed ID: 23754411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis.
    Namdee K; Thompson AJ; Golinski A; Mocherla S; Bouis D; Eniola-Adefeso O
    Atherosclerosis; 2014 Nov; 237(1):279-86. PubMed ID: 25286447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier.
    Marcos-Contreras OA; Greineder CF; Kiseleva RY; Parhiz H; Walsh LR; Zuluaga-Ramirez V; Myerson JW; Hood ED; Villa CH; Tombacz I; Pardi N; Seliga A; Mui BL; Tam YK; Glassman PM; Shuvaev VV; Nong J; Brenner JS; Khoshnejad M; Madden T; Weissmann D; Persidsky Y; Muzykantov VR
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3405-3414. PubMed ID: 32005712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale.
    Cooley M; Sarode A; Hoore M; Fedosov DA; Mitragotri S; Sen Gupta A
    Nanoscale; 2018 Aug; 10(32):15350-15364. PubMed ID: 30080212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters.
    Charoenphol P; Mocherla S; Bouis D; Namdee K; Pinsky DJ; Eniola-Adefeso O
    Atherosclerosis; 2011 Aug; 217(2):364-70. PubMed ID: 21601207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling particle shape-dependent dynamics in nanomedicine.
    Shah S; Liu Y; Hu W; Gao J
    J Nanosci Nanotechnol; 2011 Feb; 11(2):919-28. PubMed ID: 21399713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of wall shear stress and ligand avidity on binding of anti-CD146-coated nanoparticles to murine tumor endothelium under flow.
    Thomann S; Baek S; Ryschich E
    Oncotarget; 2015 Nov; 6(37):39960-8. PubMed ID: 26503468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnolol Nanoparticles Exhibit Improved Water Solubility and Suppress TNF-α-Induced VCAM-1 Expression in Endothelial Cells.
    Lee CW; Hu SC; Yen FL; Hsu LF; Lee IT; Lin ZC; Tsai MH; Huang CL; Liang CJ; Chiang YC
    J Biomed Nanotechnol; 2017 Mar; 13(3):255-68. PubMed ID: 29381027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
    Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
    PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
    Banerjee A; Qi J; Gogoi R; Wong J; Mitragotri S
    J Control Release; 2016 Sep; 238():176-185. PubMed ID: 27480450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium.
    Gonzalez-Carter D; Liu X; Tockary TA; Dirisala A; Toh K; Anraku Y; Kataoka K
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19141-19150. PubMed ID: 32703811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing potential peptide targeting ligands by quantification of cellular adhesion of model nanoparticles under flow conditions.
    Broda E; Mickler FM; Lächelt U; Morys S; Wagner E; Bräuchle C
    J Control Release; 2015 Sep; 213():79-85. PubMed ID: 26134072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic system for facilitated quantification of nanoparticle accumulation to cells under laminar flow.
    Kusunose J; Zhang H; Gagnon MK; Pan T; Simon SI; Ferrara KW
    Ann Biomed Eng; 2013 Jan; 41(1):89-99. PubMed ID: 22855121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-VCAM-1 SAINT-O-Somes enable endothelial-specific delivery of siRNA and downregulation of inflammatory genes in activated endothelium in vivo.
    Kowalski PS; Zwiers PJ; Morselt HW; Kuldo JM; Leus NG; Ruiters MH; Molema G; Kamps JA
    J Control Release; 2014 Feb; 176():64-75. PubMed ID: 24389338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.
    Kelly KA; Allport JR; Tsourkas A; Shinde-Patil VR; Josephson L; Weissleder R
    Circ Res; 2005 Feb; 96(3):327-36. PubMed ID: 15653572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-targeted delivery of dexamethasone by anti-VCAM-1 SAINT-O-Somes in mouse endotoxemia.
    Li R; Kowalski PS; Morselt HWM; Schepel I; Jongman RM; Aslan A; Ruiters MHJ; Zijlstra JG; Molema G; van Meurs M; Kamps JAAM
    PLoS One; 2018; 13(5):e0196976. PubMed ID: 29763440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
    Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
    Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line.
    Guccione C; Oufir M; Piazzini V; Eigenmann DE; Jähne EA; Zabela V; Faleschini MT; Bergonzi MC; Smiesko M; Hamburger M; Bilia AR
    Eur J Pharm Biopharm; 2017 Oct; 119():253-263. PubMed ID: 28652141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs.
    Park JH; Jiang Y; Zhou J; Gong H; Mohapatra A; Heo J; Gao W; Fang RH; Zhang L
    Sci Adv; 2021 Jun; 7(25):. PubMed ID: 34134990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.